Actin vs NowPatient
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Actin
Best for affordable compounded semaglutide with B12 enhancementStarting at $133/mo
NowPatient
Best for Brand-name GLP-1 access without a compounded routeStarting at $1069/mo
Side-by-Side Comparison
| Feature | Actin | NowPatient |
|---|---|---|
| Overall Score | ✓7.0/10 | 6.8/10 |
| Starting Price | ✓$133/mo | $1069/mo |
| Editorial Rating | ✓3.5 ★ /5 | 3.4 ★ /5 |
| Features | 2 features | 2 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Actin
Pros
- ✓Semaglutide + B12 combination for added energy support
- ✓Transparent pricing — exact cost shown upfront with no hidden fees
- ✓Competitive starting price from $133
Cons
- ✗Semaglutide only — no tirzepatide or liraglutide
- ✗No visible LegitScript or PCAB accreditation
- ✗State availability not disclosed
- ✗Broader platform (hormones, sexual wellness, hair health)
NowPatient
Pros
- ✓Free telehealth consultation — patients only pay the medication cost
- ✓Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- ✓One of the few telehealth platforms offering Wegovy in both injection and oral pill form
- ✓No compounded options — every drug is FDA-approved brand
Cons
- ✗Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
- ✗Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
- ✗State availability not disclosed publicly — determined during intake
- ✗Phone: 1-866-967-1977, HQ Austin TX
- ✗Does NOT offer Foundayo (orforglipron)
Our Verdict
Actin edges out NowPatient with a higher overall score of 7.0/10 and is particularly strong for affordable compounded semaglutide with B12 enhancement. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.